alexa Deling Kong | Nankai University
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Deling Kong

Deling Kong Deling Kong
College of Life Science 
Nankai University; Director,
The Key Laboratory of Bioactive Materials, Ministry of Education,
School of Life Science
Nanklai University
China
Biography

Dr. Kong is a Professor of Biological Chemistry, Director of the Key Laboratory of Bioactive Materials, Ministry of education at Nankai University. His research interests focus on cardiovascular regenerative medicine, including stem cell treatment of myocardium infarction and vascular grafts. In stem cell therapy, his group use bioactive hydrogel to improve the survival of the implanted stem cells and regulate their differentiation and paracrine. They also use the molecular imaging technology to track the implanted cells and study the function mechanism. Their work in vascular grafts focuses on creation of multifunctional and bioactive scaffolds with ideal material properties that can facilitate rapid endothelialization, regeneration of functional smooth muscle layer, and maintain long-term patency. Dr. Kong won the Outstanding Youth Fund of NSFC in 2007. He won the 2nd class National Scientific Technology Progress Award of China in 2009, and the 2nd class Natural Science Award of Tianjin in 2010. He was elected to the Fellow of Biomaterials Science & Engineering (FBSE) in 2016. He has published more than 200 peer reviewed papers, which were cited over 3000 times. He is also holding more than 15 approved patents.

Research Interest

His research interests focus on cardiovascular regenerative medicine, including stem cell treatment of myocardium infarction and vascular grafts.

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords